Prenetics Global Limited (PRENW)
USD 0.01
(19.0%)
USD 0.01
(19.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -47.89 Million USD | -203.48% |
| 2022 | -214.28 Million USD | 126.6% |
| 2021 | -157.69 Million USD | -28662.38% |
| 2020 | -1.41 Million USD | 96.95% |
| 2019 | -18.56 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -8.18 Million USD | 31.07% |
| 2024 Q2 | -11.28 Million USD | -16.12% |
| 2023 Q1 | -12.15 Million USD | -208.17% |
| 2023 FY | - USD | -203.48% |
| 2023 Q3 | -13.62 Million USD | -34.59% |
| 2023 Q2 | -10.12 Million USD | 16.76% |
| 2023 Q4 | -11.87 Million USD | 12.8% |
| 2022 Q2 | -139.25 Million USD | -383.09% |
| 2022 Q1 | -28.82 Million USD | 65.79% |
| 2022 Q4 | 11.23 Million USD | -38.19% |
| 2022 FY | - USD | 126.6% |
| 2022 Q3 | 18.18 Million USD | 113.06% |
| 2021 Q2 | -6.96 Million USD | -283.88% |
| 2021 FY | - USD | -28662.38% |
| 2021 Q1 | 3.79 Million USD | 303.52% |
| 2021 Q4 | -84.26 Million USD | -9.12% |
| 2021 Q3 | -77.22 Million USD | -1008.03% |
| 2020 Q2 | -1.19 Million USD | -120.25% |
| 2020 Q1 | 5.92 Million USD | 0.0% |
| 2020 FY | - USD | 96.95% |
| 2020 Q4 | -1.86 Million USD | -123.01% |
| 2020 Q3 | 8.09 Million USD | 774.54% |
| 2019 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Bionano Genomics, Inc. | -213.6 Million USD | 77.577% |
| Star Equity Holdings, Inc. | -1.68 Million USD | -2739.129% |
| CareDx, Inc | -89.65 Million USD | 46.579% |
| Exact Sciences Corporation | 41.87 Million USD | 214.376% |
| Exagen Inc. | -19.15 Million USD | -150.071% |
| Inotiv, Inc. | -26.5 Million USD | -80.699% |
| Guardant Health, Inc. | -433.3 Million USD | 88.946% |
| Biodesix, Inc. | -37.1 Million USD | -29.09% |
| BioNexus Gene Lab Corp. | -2.48 Million USD | -1827.284% |
| Precipio, Inc. | -4.31 Million USD | -1009.22% |
| iSpecimen Inc. | -9.1 Million USD | -426.116% |
| Natera, Inc. | -383.27 Million USD | 87.503% |
| Aspira Women's Health Inc. | -16.49 Million USD | -190.438% |
| Standard BioTools Inc. | -54.45 Million USD | 12.048% |
| 23andMe Holding Co. | -291.87 Million USD | 83.59% |
| Castle Biosciences, Inc. | -45.02 Million USD | -6.379% |
| Personalis, Inc. | -96.8 Million USD | 50.524% |
| Aclaris Therapeutics, Inc. | -117.56 Million USD | 59.26% |
| Applied DNA Sciences, Inc. | -9.59 Million USD | -399.384% |
| OpGen, Inc. | -29.51 Million USD | -62.299% |
| T2 Biosystems, Inc. | -43.87 Million USD | -9.165% |
| Myriad Genetics, Inc. | -67.8 Million USD | 29.357% |
| ICON Public Limited Company | 1.63 Billion USD | 102.935% |
| NeoGenomics, Inc. | -17.6 Million USD | -172.029% |
| Star Equity Holdings, Inc. | -1.68 Million USD | -2739.129% |
| IDEXX Laboratories, Inc. | 1.21 Billion USD | 103.933% |
| RadNet, Inc. | 292.78 Million USD | 116.359% |
| MDxHealth SA | -30.46 Million USD | -57.201% |
| Psychemedics Corporation | -251 Thousand USD | -18982.111% |
| Illumina, Inc. | -608 Million USD | 92.122% |
| Check-Cap Ltd. | -17.64 Million USD | -171.381% |
| Twist Bioscience Corporation | -176.7 Million USD | 72.895% |
| DarioHealth Corp. | -53.49 Million USD | 10.465% |
| Fulgent Genetics, Inc. | -46.55 Million USD | -2.887% |
| Sera Prognostics, Inc. | -35.28 Million USD | -35.733% |
| ENDRA Life Sciences Inc. | -9.78 Million USD | -389.495% |
| OPKO Health, Inc. | -65.51 Million USD | 26.894% |
| Medpace Holdings, Inc. | 363.15 Million USD | 113.189% |
| Neogen Corporation | 182.59 Million USD | 126.23% |
| Intelligent Bio Solutions Inc. | -8.81 Million USD | -443.612% |
| Prenetics Global Limited | -47.89 Million USD | -0.0% |
| Mainz Biomed B.V. | -25.01 Million USD | -91.499% |
| bioAffinity Technologies, Inc. | -7.62 Million USD | -527.791% |
| Trinity Biotech plc | -24.09 Million USD | -98.755% |
| Neuronetics, Inc. | -22.75 Million USD | -110.449% |
| Sotera Health Company | 514.14 Million USD | 109.316% |
| bioAffinity Technologies, Inc. | -7.62 Million USD | -527.791% |